ONCT - Oncternal Therapeutics GAAP EPS of -$0.17 misses by $0.03 revenue of $0.18M beats by $0.05M
2023-11-09 16:16:15 ET
More on Oncternal Therapeutics
- Oncternal stock jumps 9% on FDA fast track designation
- Seeking Alpha’s Quant Rating on Oncternal Therapeutics
- Historical earnings data for Oncternal Therapeutics
- Financial information for Oncternal Therapeutics
For further details see:
Oncternal Therapeutics GAAP EPS of -$0.17 misses by $0.03, revenue of $0.18M beats by $0.05M